TFEB–GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response

J Kim, SH Kim, H Kang, S Lee, SY Park, Y Cho… - Nature …, 2021 - nature.com
TFEB, a key regulator of lysosomal biogenesis and autophagy, is induced not only by
nutritional deficiency but also by organelle stress. Here, we find that Tfeb and its …

Effects of sphingolipids overload on red blood cell properties in Gaucher disease

L Dupuis, C Chipeaux, E Bourdelier… - Journal of cellular …, 2020 - Wiley Online Library
Gaucher disease (GD) is a genetic disease with mutations in the GBA gene that encodes
glucocerebrosidase causing complications such as anaemia and bone disease. GD is …

[HTML][HTML] Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease

T Lefebvre, N Reihani, R Daher, TB De Villemeur… - …, 2018 - ncbi.nlm.nih.gov
Gaucher disease (GD) is an inherited deficiency of glucocerebrosidase leading to
accumulation of glucosylceramide in tissues such as the spleen, liver, and bone marrow …

Serum growth differentiation factor 15, but not lactate, is elevated in patients with Parkinson's disease

N Miyaue, H Yabe, M Nagai - Journal of the Neurological Sciences, 2020 - Elsevier
Background Parkinson's disease (PD) is among the most frequently-occurring
neurodegenerative diseases in humans. Although mitochondrial dysfunction is suggested to …

Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease

I Motta, P Delbini, N Scaramellini, V Ghiandai… - Annals of …, 2024 - Springer
Anemia and hyperferritinemia are frequent findings at diagnosis of Gaucher disease (GD).
Macrophage-independent dyserythropoiesis and abnormal iron metabolism have been …

Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease

M Franco, N Reihani, M Marin… - American journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher
disease Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in …

Semaphorin 7A: A novel marker of disease activity in Gaucher disease

M Franco, N Reihani, L Dupuis, E Collec… - American journal of …, 2020 - Wiley Online Library
Gaucher disease (GD) is a recessively inherited lysosomal storage disorder in which
sphingolipids accumulates in the macrophages that transform into Gaucher cells. A growing …

[PDF][PDF] БИОХИМИЧЕСКАЯ ХАРАКТЕРИСТИКА ПЕРВИЧНЫХ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ

ЕЮ Захарова - dissertatsia.ru
Первичные митохондриальные заболевания (ПМЗ) относятся к классу наследственных
болезней обмена веществ и обусловлены нарушением структуры и функции системы …

Manifestaciones osteoarticulares de las esfingolipidosis en adultos

G Chalès, P Guggenbuhl, B Cador-Rousseau… - EMC-Aparato …, 2020 - Elsevier
El metabolismo de los esfingolípidos está regulado por varias enzimas. Un déficit en la
actividad de una enzima induce una acumulación de esfingolípidos, lo que define las …

Novel insights into the role of fetal hemoglobin in spleen function, red cell survival and ineffective erythropoiesis in sickle cell disease

S El Hoss - 2019 - theses.hal.science
Sickle cell disease (SCD) is caused by a single point mutation in the β-globin gene
generating sickle hemoglobin (HbS). Hypoxia drives HbS polymerization that is responsible …